Distribution Deal Extension Could Be A Big Deal For CVS Stock (CVS)

Simply Wall St.10-05 21:21

Cardinal Health announced it entered a binding Letter of Intent to extend its distribution agreement with CVS Health through June 30, 2032, keeping the existing scope of supply chain services in place...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2673085705?lang=en_US&edition=fundamental","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/93625-card/1788942584052","is_english":true,"pubTime":"2026-10-05 21:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2673085705","market":"nz","top_or_hot":-1,"title":"Distribution Deal Extension Could Be A Big Deal For CVS Stock (CVS)","media":"Simply Wall St.","content":"<div>\n<p>Cardinal Health announced it entered a binding Letter of Intent to extend its distribution agreement with CVS Health through June 30, 2032, keeping the existing scope of supply chain services in place...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/distribution-deal-extension-could-be-a-big-deal-for-cvs-stoc\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Distribution Deal Extension Could Be A Big Deal For CVS Stock (CVS)</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDistribution Deal Extension Could Be A Big Deal For CVS Stock (CVS)\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-10-05 21:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/distribution-deal-extension-could-be-a-big-deal-for-cvs-stoc><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Cardinal Health announced it entered a binding Letter of Intent to extend its distribution agreement with CVS Health through June 30, 2032, keeping the existing scope of supply chain services in place...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/distribution-deal-extension-could-be-a-big-deal-for-cvs-stoc\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0208291251.USD","symbol_name":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) INC","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/distribution-deal-extension-could-be-a-big-deal-for-cvs-stoc","article_id":"2673085705","we_media_id":null,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/93625-card/1788942584052"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/distribution-deal-extension-could-be-a-big-deal-for-cvs-stoc","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2673085705","pubTimestamp":1791206496,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Cardinal Health announced it entered a binding Letter of Intent to extend its distribution agreement with CVS Health through June 30, 2032, keeping the existing scope of supply chain services in place.\nThe extended Cardinal Health arrangement gives CVS Health longer line of sight on drug distribution logistics, which can support planning around costs, inventory reliability, and operational execution in its pharmacy and benefit management businesses.\nWe will now look at how CVS Health's...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0208291251.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) INC","IHF":"iShares Dow Jones U.S. Health Ca","LU0070302665.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) ACC","IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD","LU0162691827.USD":"BGF US BASIC VALUE \"A4\" INC","LU1236620750.USD":"HSBC GIF GLOBAL SUSTAINABLE LONG TERM DIVIDEND \"AM2\" (USD) INC","IE00B7SZLL34.SGD":"Legg Mason ClearBridge - Value A Acc SGD-H","LU1983299246.USD":"SCHRODER ISF HEALTHCARE INNOVATION \"A\" (USD) ACC","IE00BSNM7G36.USD":"NEUBERGER BERMAN SYSTEMATIC GLOBAL SUSTAINABLE VALUE \"A\" (USD) ACC","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","LU0072461881.USD":"BGF US BASIC VALUE \"A2\" ACC","BK4504":"桥水持仓","LU2433249047.HKD":"THEMATICS META \"R/A\" (HKD) ACC","LU1236620834.HKD":"HSBC GIF GLOBAL SUSTAINABLE LONG TERM DIVIDEND \"AM2\" (HKD) INC","CVS":"西维斯健康","BK4588":"碎股","BK4550":"红杉资本持仓","IE00BKVL7J92.USD":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD","IE00BZ1G4Q59.USD":"LEGG MASON CLEARBRIDGE US EQUITY SUSTAINABILITY LEADER \"A\"(USD) INC (A)","LU0320765489.SGD":"FTIF - Franklin Mutual US Value A Acc SGD","LU1571399168.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"IP\" (USD) ACC","LU0211331839.USD":"FRANKLIN MUTUAL GLB DISCOVERY \"A\" (USD) ACC","RTH":"零售指数ETF-HOLDRs","BK4196":"保健护理服务","LU1059921491.USD":"NORDEA 1 GLOBAL STABLE EQUITY \"HB\" (USDHDG) ACC","LU2125909247.SGD":"Natixis Thematics Meta H-R/A SGD","CVS.AU":"Cervantes Corp Ltd","BK4581":"高盛持仓","LU0432979614.USD":"JPM GLOBAL HEALTHCARE \"A\" ACC","LU0061475181.USD":"THREADNEEDLE (LUX) AMERICAN \"AU\" (USD) ACC","LU1923622614.USD":"Natixis Thematics Meta R/A USD","LU1699723380.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"AP\" (USD) ACC","LU0006061336.USD":"Blackrock US Small and MidCap Opportunities A2 USD","IE00B19Z3581.USD":"Legg Mason ClearBridge - Value A Acc USD","LU0859254822.USD":"T ROWE PRICE GLOBAL VALUE EQUITY \"A\" (USD) ACC","BK4585":"ETF&股票定投概念","LU2125909593.SGD":"Natixis Thematics Meta R/A SGD","LU2357627491.SGD":"TRP GLOBAL VALUE EQUITY \"AH\" (SGDHDG) ACC"},"translate_title":"分销交易延期对于 CVS 股票 (CVS) 来说可能是一件大事","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CVS.AU":1.5,"IHF":0.6,"CVS":1.5,"RTH":0.6},"content_text":"Cardinal Health announced it entered a binding Letter of Intent to extend its distribution agreement with CVS Health through June 30, 2032, keeping the existing scope of supply chain services in place. The extended Cardinal Health arrangement gives CVS Health longer line of sight on drug distribution logistics, which can support planning around costs, inventory reliability, and operational execution in its pharmacy and benefit management businesses. We will now look at how CVS Health's investment narrative could be shaped by this extended Cardinal Health distribution agreement.  Scan how CVS Health's extended Cardinal Health deal and confirmed dividend compare with peers by zeroing in on list of solid balance sheet and fundamentals (25 results). AdvertisementCVS Health Investment Narrative Recap Owning CVS Health means believing the integrated model of insurance, pharmacy benefit management, and retail can steady earnings even when individual segments run hot or cold. The extended Cardinal Health agreement mainly affects the pharmacy and Caremark operations by supporting drug availability and cost visibility, but it does not directly change the key short term swing factors in insurance and care delivery. The near term catalyst still sits in Aetna margin restoration and disciplined pricing, along with execution on cost based pharmacy models such as CostVantage. The biggest risk remains pressure on medical benefit ratios and membership, plus ongoing 340B headwinds, which the Cardinal Health deal does not remove but could help offset at the operational logistics level. The confirmed US$0.665 quarterly dividend matters for anyone viewing CVS Health as an income plus recovery story. It indicates that the board is keeping the cash return framework intact while management works through medical cost, membership and PBM contract challenges, rather than prioritising rapid shifts in capital allocation at this stage. That payout, alongside a stated yield of 3.08%, sits against a backdrop of forecast earnings growth of 17.65% per year and net income of US$4.9b on US$412.6b of revenue. For catalysts, the consistency of the dividend places more focus on whether execution in Aetna, Caremark, GLP 1 offerings and AI driven cost savings can support the current distribution without amplifying balance sheet risk from already high debt levels. CVS Health's narrative projects US$458.7b revenue and US$11.3b earnings by 2029. This implies 3.6% yearly revenue growth and an earnings increase of about US$6.4b from the current US$4.9b base. Uncover how CVS Health's fair value reflects a 34% potential upside to its current price that could narrow quickly. NYSE:CVS 1-Year Stock Price Chart Exploring Other Perspectives Five fair value estimates from the Simply Wall St Community span roughly US$104 at the low end to about US$272 at the top, which shows how far opinions on CVS Health can stretch. Before the Cardinal Health extension and confirmed dividend, these private investors were already split. Compare that spread with risks around medical benefit ratios and membership to see how sharply viewpoints can diverge and why it helps to review several community perspectives before forming a view. Explore 4 other CVS Health fair value estimates, including one that suggests it could be worth just $104.01! Form Your Own Verdict Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so consider forming your own view.  A great starting point for your CVS Health research is our analysis highlighting 4 key rewards and 2 important warning signs that could impact your investment decision. See our latest analysis for CVS Health. The report includes a comprehensive fundamental analysis summarized in a single visual, the Snowflake, making it easy to evaluate CVS Health's overall financial health at a glance.  Looking For More CVS Health Investment Ideas? If the CVS Health story has sharpened your thinking, it can help to widen the lens and compare it with other opportunities using the Simply Wall St Screener. That way you keep context on risk, income and quality rather than assessing CVS Health in isolation.  If you want potential upside coupled with balance sheet strength, scan through a 31 high quality undervalued stocks to see which businesses pair quality fundamentals with prices that look beaten down on the numbers. For investors who put capital preservation first, filter for stability by reviewing a 31 resilient stocks with low risk scores that screens for resilient stocks with lower risk scores. If you like the idea of backing underfollowed opportunities, look across a 19 high quality undiscovered gems that highlights high quality companies with strong fundamentals that are not widely tracked.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n        and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n        financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n        Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n        Simply Wall St has no position in any stocks mentioned.New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2673085705","isCrawlerRequest":true}